Startseite Kongressberichte & Archiv ASCO Annual Meeting 2017 Head & Neck Cancer Highlights Cetuximab in Combination With Chemoradiotherapy Before Surgery in Patients With Resectable, Locally Advanced Esophageal Carcinoma: A Prospective, Multicenter Phase IB/II Trial (SAKK 75/06)

PD Dr. Thomas Ruhstaller, Stv. Chefarzt Brustzentrum St.Gallen comments the study:

Cetuximab in Combination With Chemoradiotherapy Before Surgery in Patients With Resectable, Locally Advanced Esophageal Carcinoma: A Prospective, Multicenter Phase IB/II Trial (SAKK 75/06)

(Paper):

 

ASCO2017Thomas Ruhstaller from Oncoletter on Vimeo.